BTCS Inc.

MUN:BIC Stock Report

Market Cap: €44.1m

BTCS Management

Management criteria checks 3/4

BTCS' CEO is Charles Allen, appointed in Feb 2014, has a tenure of 10.92 years. total yearly compensation is $804.32K, comprised of 51.2% salary and 48.8% bonuses, including company stock and options. directly owns 25.24% of the company’s shares, worth €11.14M. The average tenure of the management team and the board of directors is 7 years and 10.3 years respectively.

Key information

Charles Allen

Chief executive officer

US$804.3k

Total compensation

CEO salary percentage51.2%
CEO tenure10.9yrs
CEO ownership25.2%
Management average tenure7yrs
Board average tenure10.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Charles Allen's remuneration changed compared to BTCS's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

US$4m

Jun 30 2024n/an/a

US$10m

Mar 31 2024n/an/a

US$15m

Dec 31 2023US$804kUS$411k

US$8m

Sep 30 2023n/an/a

-US$893k

Jun 30 2023n/an/a

US$1m

Mar 31 2023n/an/a

-US$5m

Dec 31 2022US$3mUS$369k

-US$16m

Sep 30 2022n/an/a

-US$10m

Jun 30 2022n/an/a

-US$13m

Mar 31 2022n/an/a

-US$10m

Dec 31 2021US$10mUS$377k

-US$16m

Sep 30 2021n/an/a

-US$21m

Jun 30 2021n/an/a

-US$18m

Mar 31 2021n/an/a

-US$14m

Dec 31 2020US$1mUS$361k

-US$3m

Sep 30 2020n/an/a

-US$3m

Jun 30 2020n/an/a

-US$2m

Mar 31 2020n/an/a

-US$2m

Dec 31 2019US$601kUS$345k

-US$2m

Sep 30 2019n/an/a

-US$1m

Jun 30 2019n/an/a

-US$1m

Mar 31 2019n/an/a

-US$1m

Dec 31 2018US$256kUS$256k

-US$832k

Compensation vs Market: Charles's total compensation ($USD804.32K) is above average for companies of similar size in the German market ($USD460.80K).

Compensation vs Earnings: Charles's compensation has been consistent with company performance over the past year.

CEO

Charles Allen (49 yo)

10.9yrs

Tenure

US$804,323

Compensation

Mr. Charles W. Allen is Independent Director of 60 Degrees Pharmaceuticals, Inc. from July 11, 2023. He serves as Director at Innovation1 Biotech Inc. since December 05, 2022 and serves as its Treasurer an...

Leadership Team

NamePositionTenureCompensationOwnership
Charles Allen
Chairman & CEO10.9yrsUS$804.32k25.24%
€ 11.1m
Michal Handerhan
Co-Founder10.9yrsUS$471.72k9.42%
€ 4.2m
Michael Prevoznik
Chief Financial Officer3.1yrsUS$384.77k2.78%
€ 1.2m
Manish Paranjape
Chief Technology Officer2.9yrsno data2.45%
€ 1.1m

7.0yrs

Average Tenure

48yo

Average Age

Experienced Management: BIC's management team is seasoned and experienced (7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Charles Allen
Chairman & CEO10.9yrsUS$804.32k25.24%
€ 11.1m
Michal Handerhan
Co-Founder10.9yrsUS$471.72k9.42%
€ 4.2m
Ashley DeSimone
Independent Directorless than a yearno data0.16%
€ 69.0k
William O'Brien
Member of Advisory Board10.3yrsno datano data
David Bailey
Member of Advisory Board10.3yrsno datano data
Patrick Cines
Member of Advisory Board10.3yrsno datano data
Bruce Fenton
Member of Advisory Board10.3yrsno datano data
Jeremy Gardner
Member of Advisory Board10.3yrsno datano data
Jason King
Member of Advisory Board10.3yrsno datano data
Jonathan Silverman
Member of Advisory Board10.3yrsno datano data
Changpeng Zhao
Member of Advisory Board10.3yrsno datano data
Melanie Pump
Independent Director2.3yrsUS$85.00k0.22%
€ 98.5k

10.3yrs

Average Tenure

47yo

Average Age

Experienced Board: BIC's board of directors are seasoned and experienced ( 10.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/03 16:58
End of Day Share Price 2024/12/11 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BTCS Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kevin DedeH.C. Wainwright & Co.